Helicobacter pylori Infection: Causes, Diseases, and Associated Symptoms
Helicobacter pylori (H. pylori) is a type of a bacterium that resides in the lining of the stomach and is the main cause of most cases of peptic ulcer. This bacterium is remarkably common; approximately half of the world's population is colonized by it, making it the bacterial infection most frequent in humans [1].
The prevalence of infection by H. pylori is significantly higher in developing nations. The risk of acquiring it is closely correlated with low socioeconomic status socioeconomic status and precarious living conditions, such as overcrowding, lack of potable water, and having a larger number of siblings. Therefore, in developing countries, most children become infected before the age of 10.
In regions like New Zealand, there is a higher predominance prevalence of the bacterium among Māori and Polynesian populations. In fact, studies contrast that, while only about 5% of European children are infected with H. pylori by age 20, this figure rises to 50% in Polynesian children [2].
Although the precise route of transmission is still being investigated, person-to-person transmission through oral-oral or fecal-oral exposure is considered most likely. Practices such as sharing utensils, food, or poor bathroom hygiene can facilitate the spread of H. pylori among individuals.
Diseases Related to H. pylori Infection
H. pylori directly causes various gastric conditions. However, it is important to consider that other pathologies may be linked to the body's specific immune response against this bacterium.
- Chronic gastritis (the inflammation of the stomach lining).
- Peptic ulcers..
- Different types of gastric cancer.
- Certain types of lymphomas (cancers originating in lymphoid tissue). lymphoid).
Common Symptoms of H. pylori Infection
The vast majority of people infected with H. pylori experience no discernible symptoms. Clinical manifestations usually only appear if the chronic presence of the bacterium has caused peptic ulcers or gastritis. It is important to note that these symptoms can be nonspecific and include the following:
- Abdominal pain, generally located in the upper abdomen.
- Feeling of nausea.
- Vomiting.
- Abdominal distension or bloating.
- Dark or tarry stools, indicative of possible gastrointestinal bleeding.
- Low blood count or anemia.
Mechanism of Damage: How Does H. pylori Affect the Stomach Lining?
The deterioration of the stomach lining is the result of a complex interaction between the bacterium and the host's immune response. host. H. pylori secretes various muscle enzymes enzymes and microbial byproducts that directly attack the gastric mucosa. Consequently, the immune system responds by activating an intense inflammatory response in its attempt to eradicate the pathogen. Unfortunately, this inflammatory response ultimately causes collateral and unintentional damage to the stomach's protective epithelium.
Diagnostic Evaluation: Available Tests to Detect H. pylori
There are various validated methodologies to confirm the presence of H. pylori infection in the individual. These tests focus both on detecting the active presence of the bacterium and identifying markers of past or present infection.
Diagnosis and Treatment of *H. pylori* Infection in the Stomach
Detecting the *Helicobacter pylori* (*H. pylori*) bacterium in the stomach requires several specialized tests. These can be classified according to their invasive nature and reliability:
- Blood tests: Identifies the presence of undetectable antibodies a bacterium generated against *H. pylori*.
- Breath test: It is a non-invasive method where the patient ingests a solution solution containing carbon-labeled urea. If *H. pylori* is present, it breaks down this solution, and the degradation products are detected in the patient's exhalation.
- Stool test: It specifically looks for the proteins proteins produced by *H. pylori* in fecal samples.
- Endoscopic Tests: They involve the use of flexible optical instruments (endoscope) inserted through the mouth into the stomach and the upper part of the small intestine for visual inspection. During this procedure, small tissue samples from the gastric wall can be taken (Endoscopic Tests) for subsequent analysis for *H. pylori*.
Generally, blood tests and breath tests are the preferred initial options for *H. pylori* screening. Because it requires a more invasive procedure, the biopsy invasive, , biopsy obtained via an endoscopy endoscopy is often reserved for patients who already require an endoscopy endoscopy for other conditions.
Who Should Be Tested for *H. pylori*?
The American College of Gastroenterology (ACG) suggests that *H. pylori* testing is a priority in the following clinical scenarios [3]:
- Patients with active peptic ulcer disease.
- Those with a documented history of previous peptic ulcer.
- Patients diagnosed with Gastric Lymphoma Mucosa-Associated Lymphoid Tissue (MALT lymphoma). Mucosal Mucosa-Associated lymphoma Gastric tissue (MALT lymphoma).
- Patients who have undergone an early gastric cancer resection. after initial of cancer early gastric cancer.
Screening is not considered a first line for individuals who are completely asymptomatic asymptomatic and have no history of ulcer disease. Nevertheless, evaluation should be considered in certain population groups that historically have a higher risk of developing ulcers or gastric neoplasms.
Treatment Options for *H. pylori* Eradication
Effective treatment for *H. pylori* infection commonly involves a multiple-drug regimen taken over a period of 7 to 14 days, known as "triple therapy." A standard example includes the administration of a tyrosine proton pump inhibitor (PPI), such as omeprazole 40 mg once daily, combined with two antibiotics: amoxicillin 1 g twice daily and clarithromycin 500 mg twice daily.
Fortunately, if the regimen is followed correctly, this treatment cures the infection in up to 90% of treated individuals.
Relationship between *H. pylori* and Dermatological Diseases
*H. pylori* has been associated with a range of pathologies that extend beyond the gastrointestinal tract. Skin conditions are an area of interest, and various scientific studies have postulated a connection with the following conditions [4,5]:
- Chronic Spontaneous Urticaria: Several studies have established a link between the persistence of *H. pylori* infection and chronic urticaria. It is theorized that the infection increases the vascular permeability Contact of the gastric lining. This increased permeability facilitates greater exposure to contactAllergens (substances capable of triggering an allergy) histamine present in the digestive tract. Additionally, the immune response generated against *H. pylori* leads to the production of antibodies capable of stimulating the release of.
histamine.
- in the skin tissues. erythema Understanding these systemic connections underscores the importance of eradicating *H. pylori* not only to prevent ulcers but also to potentially improve various associated skin manifestations.
- Rosacea: The presence of *H. pylori* could increase blood or tissue levels of nitric oxide, which potentially exacerbates the redness and organism erythema.
- characteristic of rosacea. defect Psoriasis: It is being investigated whether *H. pylori* is one of the nodes, organisms.
- Purpura Henoch-Schönlein
- Diffuse areata
- Sweet's Syndrome
- Sclerosis systemic sclerosis)
- Dermatitis atopic
- Behçet's Disease
- Pruritus generalized (itching)
- Prurigo nodular
- capable of triggering the inflammatory response associated with psoriasis.
- Lichen Planus
- Ulcer Sjögren's Syndrome: *H. pylori* can induce an.
autoimmune response
directed against the skin and glands, manifesting as Sjögren's syndrome.
Henoch-Schönlein Purpura.
Alopecia areata randomized Sweet's disease.
